Literature DB >> 16624284

Regulation of C/EBPbeta isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3.

Ewa Marcinkowska1, Edward Garay, Elzbieta Gocek, Agnieszka Chrobak, Xuening Wang, George P Studzinski.   

Abstract

C/EBPbeta is known to be important for monocytic differentiation and macrophage function. Here, we found that expression of all three C/EBPbeta isoforms induced in HL60 cells by 1,25-dihydroxyvitamin D3 (1,25D) was upregulated in a sustained manner that correlates with the appearance of monocytic phenotype and with the G1 phase cell cycle arrest. In 1,25D-resistant HL60-40AF cells, isoforms beta-1 and beta-3 were expressed at levels comparable to 1,25D-sensitive HL60-G cells, but isoform beta-2 was difficult to detect. Treatment of sensitive HL60 cells with 1,25D resulted in predominantly nuclear localization of C/EBP isoforms beta-2 and beta-3, while a large proportion of C/EBPbeta-1 remained in the cytoplasm. Attenuation of the MEK-ERK MAPK pathway by the inhibitor PD98059 markedly reduced the expression, 1,25D-induced phosphorylation and nuclear localization of C/EBPbeta-2 and C/EBPbeta-3. Interestingly, only the lower molecular mass isoforms of C/EBPbeta phosphorylated on Thr235 were found in the nuclei, while C/EBPbeta-1 was constitutively phosphorylated and was detected principally in the cytoplasmic fraction. Although the role of C/EBPbeta isoforms in 1,25D-induced differentiation is complex, our results taken together strongly suggest that the phosphorylation of C/EBPbeta isoforms on Thr235 takes place mainly via the MEK-ERK pathway and that C/EBPbeta-2 is the principal transcription factor in this cell system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16624284      PMCID: PMC2814412          DOI: 10.1016/j.yexcr.2006.03.003

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  78 in total

1.  Characterization of C/EBPbeta isoforms in normal versus neoplastic mammary epithelial cells.

Authors:  E M Eaton; M Hanlon; L Bundy; L Sealy
Journal:  J Cell Physiol       Date:  2001-10       Impact factor: 6.384

Review 2.  Docking interactions in the mitogen-activated protein kinase cascades.

Authors:  Takuji Tanoue; Eisuke Nishida
Journal:  Pharmacol Ther       Date:  2002 Feb-Mar       Impact factor: 12.310

3.  CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling.

Authors:  Songyun Zhu; Kyungsil Yoon; Esta Sterneck; Peter F Johnson; Robert C Smart
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

4.  Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.

Authors:  T Pabst; B U Mueller; P Zhang; H S Radomska; S Narravula; S Schnittger; G Behre; W Hiddemann; D G Tenen
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

5.  Inhibition of p38MAP kinase potentiates the JNK/SAPK pathway and AP-1 activity in monocytic but not in macrophage or granulocytic differentiation of HL60 cells.

Authors:  X Wang; G P Studzinski
Journal:  J Cell Biochem       Date:  2001 Apr 2-27       Impact factor: 4.429

6.  C/EBPbeta phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival.

Authors:  M Buck; V Poli; T Hunter; M Chojkier
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

7.  C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4.

Authors:  H Wang; P Iakova; M Wilde; A Welm; T Goode; W J Roesler; N A Timchenko
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

Review 8.  CCAAT/enhancer-binding proteins: structure, function and regulation.

Authors:  Dipak P Ramji; Pelagia Foka
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

9.  Retinoblastoma protein complexes with C/EBP proteins and activates C/EBP-mediated transcription.

Authors:  A Charles; X Tang; E Crouch; J S Brody; Z X Xiao
Journal:  J Cell Biochem       Date:  2001 Aug 21-Sep 5       Impact factor: 4.429

10.  Evidence that activation of MEK1,2/erk1,2 signal transduction pathway is necessary for calcitriol-induced differentiation of HL-60 cells.

Authors:  E Marcinkowska
Journal:  Anticancer Res       Date:  2001 Jan-Feb       Impact factor: 2.480

View more
  28 in total

1.  RhoA-mediated signaling up-regulates hepatocyte growth factor gene and protein expression in response to apoptotic cells.

Authors:  Hyun-Jung Park; Youn-Hee Choi; Young Joo Cho; Peter M Henson; Jihee Lee Kang
Journal:  J Leukoc Biol       Date:  2010-12-10       Impact factor: 4.962

Review 2.  Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis.

Authors:  Daniel E Johnson
Journal:  Adv Enzyme Regul       Date:  2007-11-19

3.  MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis.

Authors:  Elzbieta Gocek; Xuening Wang; Xiuping Liu; Chang-Gong Liu; George P Studzinski
Journal:  Cancer Res       Date:  2011-08-04       Impact factor: 12.701

Review 4.  Vitamin D and differentiation in cancer.

Authors:  Elzbieta Gocek; George P Studzinski
Journal:  Crit Rev Clin Lab Sci       Date:  2009       Impact factor: 6.250

5.  Dual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1α,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistance.

Authors:  Xiangwen Chen-Deutsch; George P Studzinski
Journal:  Cell Cycle       Date:  2012-04-01       Impact factor: 4.534

Review 6.  Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks.

Authors:  René Huber; Daniel Pietsch; Johannes Günther; Bastian Welz; Nico Vogt; Korbinian Brand
Journal:  Cell Mol Life Sci       Date:  2013-03-24       Impact factor: 9.261

7.  1,25-Dihydroxyvitamin D3 induces monocytic differentiation of human myeloid leukemia cells by regulating C/EBPβ expression through MEF2C.

Authors:  Ruifang Zheng; Xuening Wang; George P Studzinski
Journal:  J Steroid Biochem Mol Biol       Date:  2014-11-20       Impact factor: 4.292

8.  Silibinin can induce differentiation as well as enhance vitamin D3-induced differentiation of human AML cells ex vivo and regulates the levels of differentiation-related transcription factors.

Authors:  Jing Zhang; Jonathan S Harrison; Milan Uskokovic; Michael Danilenko; George P Studzinski
Journal:  Hematol Oncol       Date:  2010-09       Impact factor: 5.271

9.  Expression of human kinase suppressor of Ras 2 (hKSR-2) gene in HL60 leukemia cells is directly upregulated by 1,25-dihydroxyvitamin D(3) and is required for optimal cell differentiation.

Authors:  Xuening Wang; Tian-Tian Wang; John H White; George P Studzinski
Journal:  Exp Cell Res       Date:  2007-05-31       Impact factor: 3.905

Review 10.  Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapy.

Authors:  Philip J Hughes; Ewa Marcinkowska; Elzbieta Gocek; George P Studzinski; Geoffrey Brown
Journal:  Leuk Res       Date:  2009-10-06       Impact factor: 3.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.